Literature DB >> 1803992

Effect of clavulanic acid on activity of beta-lactam antibiotics in Serratia marcescens isolates producing both a TEM beta-lactamase and a chromosomal cephalosporinase.

K Bush1, R K Flamm, S Ohringer, S B Singer, R Summerill, D P Bonner.   

Abstract

An isolate of Serratia marcescens that produced both an inducible chromosomal and a plasmid-mediated TEM-1 beta-lactamase was resistant to ampicillin and amoxicillin and also demonstrated decreased susceptibility to extended-spectrum beta-lactam antibiotics (ESBAs). Clavulanic acid did not lower the MICs of the ESBAs, but it decreased the MICs of the penicillins. The TEM-1-producing plasmid was transferred to a more susceptible S. marcescens strain that produced a well-characterized inducible chromosomal beta-lactamase. The MICs of the ESBAs remained at a low level for the transconjugant. Ampicillin and amoxicillin which were good substrates for the plasmid-mediated enzyme, were not well hydrolyzed by the chromosomal enzymes; the ESBAs were hydrolyzed slowly by all the enzymes. When each of the S. marcescens strains was grown with these beta-lactam antibiotics, at least modest increases in chromosomal beta-lactamase activity were observed. When organisms were grown in the presence of clavulanic acid and an ESBA, no enhanced induction was observed. The increases in the MICs of the ESBAs observed for the initial clinical isolate may have been due to a combination of low inducibility, slow hydrolysis, and differences in permeability between the S. marcescens isolates. When clavulanic acid and a penicillin were added to strains that produced both a plasmid-mediated TEM and a chromosomal beta-lactamase, much higher levels of chromosomal beta-lactamase activity were present than were observed in cultures induced by the penicillin alone. This was due to the higher levels of penicillin that were available for induction as a result of inhibition of the TEM enzyme by clavulanate.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1803992      PMCID: PMC245360          DOI: 10.1128/AAC.35.11.2203

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Effective cooling allows sonication to be used for liberation of beta-lactamases from gram negative bacteria.

Authors:  K Bush; S B Singer
Journal:  J Antimicrob Chemother       Date:  1989-07       Impact factor: 5.790

2.  A comparison of agar dilution, identification of beta-lactamases and disc diffusion methods for assessing the sensitivity to ticarcillin-clavulanic acid.

Authors:  B Joly; M Chanal; D Sirot; M Cluzel; J Sirot; R Cluzel
Journal:  J Antimicrob Chemother       Date:  1986-05       Impact factor: 5.790

Review 3.  Induction of beta-lactamases.

Authors:  G M Eliopoulos
Journal:  J Antimicrob Chemother       Date:  1988-07       Impact factor: 5.790

4.  Clavulanate and beta-lactamase induction.

Authors:  D M Livermore; M Akova; P J Wu; Y J Yang
Journal:  J Antimicrob Chemother       Date:  1989-11       Impact factor: 5.790

5.  In vitro evaluation of tigemonam, a novel oral monobactam.

Authors:  S K Tanaka; R A Summerill; B F Minassian; K Bush; D A Visnic; D P Bonner; R B Sykes
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

6.  The effects of clavulanic acid and sulbactam on beta-lactamase biosynthesis.

Authors:  T H Farmer; C Reading
Journal:  J Antimicrob Chemother       Date:  1988-08       Impact factor: 5.790

7.  Beta-lactamase production in members of the family Enterobacteriaceae and resistance to beta-lactam-enzyme inhibitor combinations.

Authors:  K S Thomson; D A Weber; C C Sanders; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

8.  Amoxicillin plus clavulanic acid in the treatment of recurrent urinary tract infections.

Authors:  W Brumfitt; J M Hamilton-Miller
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

9.  Diverse potential of beta-lactamase inhibitors to induce class I enzymes.

Authors:  D A Weber; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

10.  Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.

Authors:  J P Quinn; D Miyashiro; D Sahm; R Flamm; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

View more
  7 in total

1.  Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests.

Authors:  K S Thomson; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

2.  Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum beta-lactamase to other members of the family enterobacteriaceae.

Authors:  C Neuwirth; E Siebor; J Lopez; A Pechinot; A Kazmierczak
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

Review 3.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

4.  Mutation in Serratia marcescens AmpC beta-lactamase producing high-level resistance to ceftazidime and cefpirome.

Authors:  A Raimondi; F Sisto; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

5.  In vitro susceptibility of characterized β-lactamase-producing strains tested with avibactam combinations.

Authors:  Henry Li; Mark Estabrook; George A Jacoby; Wright W Nichols; Raymond T Testa; Karen Bush
Journal:  Antimicrob Agents Chemother       Date:  2014-12-22       Impact factor: 5.191

6.  SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strains.

Authors:  A M Queenan; C Torres-Viera; H S Gold; Y Carmeli; G M Eliopoulos; R C Moellering; J P Quinn; J Hindler; A A Medeiros; K Bush
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

7.  Occurrence and phenotypic characteristics of extended-spectrum beta-lactamases among members of the family Enterobacteriaceae at the Tel-Aviv Medical Center (Israel) and evaluation of diagnostic tests.

Authors:  Shiri Navon-Venezia; Orly Hammer-Munz; David Schwartz; Dan Turner; Boris Kuzmenko; Yehuda Carmeli
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.